HSP70 desensitizes osteosarcoma cells to baicalein and protects cells from undergoing apoptosis

Lianghua Ding1, Shuanghua He, Xiaoliang Sun

  • 1Department of Orthopedics, The Third Affiliated Hospital of Suzhou University, No 185 Juqian Street, Changzhou, 213003, China.

Insights

Baicalein induces apoptosis in osteosarcoma cells through a mitochondrial pathway. Targeting heat shock protein 70 (HSP70) may overcome drug resistance in cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Baicalein demonstrates broad-spectrum anti-cancer properties.
  • The effects of baicalein on osteosarcoma and its resistance mechanisms are not well understood.
  • Chemotherapy resistance is a significant challenge in treating osteosarcoma.

Purpose of the Study:

  • To investigate the anti-tumor effects of baicalein on human osteosarcoma cells.
  • To elucidate the molecular mechanisms underlying baicalein's action.
  • To identify potential mechanisms of drug resistance.

Main Methods:

  • Cell viability assays to assess baicalein's effect.
  • Apoptosis assays to detect programmed cell death.
  • Western blotting to analyze protein expression (HSP70, caspases, PI3K/AKT, MAPK/ERK pathways).

Main Results:

  • Baicalein induced apoptosis in osteosarcoma cells via mitochondrial pathways (caspase-dependent and independent).
  • Baicalein upregulated heat shock protein 70 (HSP70) expression, conferring partial resistance to apoptosis.
  • HSP70 activation of PI3K/AKT and MAPK/ERK pathways reduced osteosarcoma cell sensitivity to baicalein.

Conclusions:

  • Baicalein exhibits anti-osteosarcoma activity by inducing apoptosis.
  • HSP70 plays a crucial role in baicalein resistance through PI3K/AKT and MAPK/ERK signaling.
  • Targeting HSP70 in combination with baicalein could be a promising therapeutic strategy for osteosarcoma.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K